Key facts
- This page summarizes Sujal M. Patel's Form 4 filing for Nautilus Biotechnology, Inc. (NAUT).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 04 Mar 2026, 18:37.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Purchase
No transaction description listed
No transaction description listed
Additional SEC filing notes
Footnote F1
Represents the weighted average share price of an aggregate total of 25,000 shares purchased in the price range of $2.48 to $2.6095 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
Footnote F2
Shares held by PFV I, LLC. The reporting person is the manager of PFV I, LLC.
Footnote F3
Shares held by Sujal Patel 2020 Children's Trust, u/a/d December 3, 2020 (the "Patel Trust"). The reporting person and the reporting person's spouse are the trustees of the Patel Trust.